Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report

The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revista da Sociedade Brasileira de Medicina Tropical 2021-01, Vol.54
Hauptverfasser:	Menegali, Bruno Thizon, Schuelter-Trevisol, Fabiana, Barbosa, Alexandre Naime, Izidoro, Talita Menegali, Feurschuette, Otto Henrique May, Marcon, Chaiana Esmeraldino Mendes, Trevisol, Daisson José
Format:	Artikel
Sprache:	eng
Schlagworte:	Case Report Coronavirus infections Immunization passive TROPICAL MEDICINE Vaccine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to report a case of passive anti-SARS-CoV-2 immunity in a newborn through immunoprophylaxis of a pregnant woman who received the CoronaVac® vaccine in the third trimester of pregnancy. Twenty-four hours after delivery, samples were collected from the newborn and screened by enzyme immunoassays, which revealed antibodies to SARS-CoV-2.
ISSN:	0037-8682 1678-9849 1678-9849
DOI:	10.1590/0037-8682-0385-2021